Adial PharmaceuticalsADIL
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$0.22avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Adial Pharmaceuticals Inc. (ADIL) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Raffa Wealth Management, LLC ($460).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Raffa Wealth Management, LLC | 0.00% | No change | 2,093 | $460 |
"% of holder's portfolio" is ADIL's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.